Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea

Brief description of study

The primary objective of this post-marketing surveillance study is to collect and assess data related to the safety and effectiveness of Harvoni (ledipasvir/sofosbuvir (LDV/SOF)) treatment regimen, per the approved Korea prescribing information for Harvoni, in routine clinical practice in Korea and to report the results to the Ministry of Food and Drug Safety (MFDS). Patients will be treated as part of routine practice at Korean healthcare centers by accredited physicians.

Clinical Study Identifier: NCT02951364

Start Over